Mutya Harsch - 11 Oct 2021 Form 4 Insider Report for Satsuma Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Thomas P. O'Neil as Attorney in Fact for Mutya Harsch
Issuer symbol
N/A
Transactions as of
11 Oct 2021
Net transactions value
$0
Form type
4
Filing time
12 Oct 2021, 17:17:04 UTC
Previous filing
01 Oct 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STSA Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 11 Oct 2021 Common Stock 40,000 $4.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The award shall vest as to 1/36 of the shares subject to the award on each monthly anniversary from October 11, 2021, subject to continued service through each applicable vesting date